摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-5-氟苄醇 | 202865-66-5

中文名称
2-溴-5-氟苄醇
中文别名
2-溴-5-氟苯甲醇;(2-溴-5-氟苯基)甲醇
英文名称
2-bromo-5-fluorobenzyl alcohol
英文别名
(2-bromo-5-fluorophenyl)methanol
2-溴-5-氟苄醇化学式
CAS
202865-66-5
化学式
C7H6BrFO
mdl
——
分子量
205.026
InChiKey
HXGZPMHPSBJMKB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    91-94 °C
  • 沸点:
    252.5±25.0 °C(Predicted)
  • 密度:
    1.658±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S26,S36
  • 危险类别码:
    R22,R36
  • WGK Germany:
    3
  • 危险性防范说明:
    P273,P305+P351+P338
  • 危险性描述:
    H302,H319,H412
  • 储存条件:
    室温环境下。

SDS

SDS:512c452676e178a5dd8787d611f3f492
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 2-Bromo-5-fluorobenzyl alcohol
CAS-No. : 202865-66-5
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Oral (Category 4)
Eye irritation (Category 2)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Harmful if swallowed. Irritating to eyes.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
H319 Causes serious eye irritation.
Precautionary statement(s)
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R22 Harmful if swallowed.
R36 Irritating to eyes.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S36 Wear suitable protective clothing.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C7H6BrFO
Molecular Weight : 205,02 g/mol
Component Concentration
2-Bromo-5-fluorobenzyl alcohol
CAS-No. 202865-66-5 -

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Hydrogen bromide gas, Hydrogen fluoride
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: Powder with lumps
Colour: yellow
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 91 - 94 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 2,201
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion Harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
Toxicity to fish LC50 - Pimephales promelas (fathead minnow) - 25,2 mg/l - 96 h
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
Harmful to aquatic life.
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

制备方法与用途

用途

2-溴-5-氟苄醇是一种重要的工业原料,广泛应用于医药、农药和染料等行业。由于其结构具有良好的生物活性,在药物合成方面具有不可替代的作用,因此在医药研究中是一个热点领域。此外,该化合物还具有特殊的化学性质和药用活性,作为许多医药及农药的中间体,其应用前景非常广阔[7]。它还可用于医药及医药中间体、染发助剂、聚合物稳定剂、感光材料的抗氧化剂以及抗灰雾剂等。

合成方法

2-溴-5-氟苄醇的制备方法如下:在室温下,将2-溴-5-氟苯甲酸甲酯(1 g,4.292 mmol)、NaBH4(0.423 g,11.159 mmol)和LiCl(0.474 g,11.159 mmol)加入到THF/EtOH(20 ml/10 ml)的混合物中搅拌过夜。随后添加含水HCl(10 ml,2N),继续搅拌约10分钟。之后在低真空下除去有机溶剂,并用水稀释残留物后用乙酸乙酯萃取。使用含水NaHCO3(10%)、水和盐水洗涤有机层,再经过MgSO4干燥并浓缩,得到粗产品2-溴-5-氟苄醇。无需进一步纯化,即可直接使用,收率为852 mg(96.8%)。

![](图 2-溴-5-氟苄醇的合成路线)

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    [EN] NOVEL PROCESS FOR THE PREPARATION OF TAVABOROLE, ITS NOVEL POLYMORPHIC FORMS AND THE POLYMORPHS THEREOF
    [FR] NOUVEAU PROCÉDÉ DE PRÉPARATION DE TAVABOROLE, SES NOUVELLES FORMES POLYMORPHES ET POLYMORPHES ASSOCIÉS
    摘要:
    该发明涉及一种新型塔伐博瑞的制备工艺。该发明还涉及塔伐博瑞的新型多形态形式以及制备这些多形态形式的工艺。该发明还涉及一种用于纯化塔伐博瑞以获得高产率和基本纯净形式的工艺。
    公开号:
    WO2017183043A1
  • 作为产物:
    描述:
    2-溴-5-氟苯甲酸甲酯 在 sodium tetrahydroborate 、 lithium chloride盐酸 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 0.17h, 生成 2-溴-5-氟苄醇
    参考文献:
    名称:
    基于4-苯基-6-(2,2,2-三氟-1-苯基乙氧基) 嘧啶的化合物及其应用方法
    摘要:
    本发明涉及基于4‑苯基‑6‑(2,2,2‑三氟‑1‑苯基乙氧基)嘧啶的化合物及其应用方法。具体地,本发明公开了式I化合物,以及包含它们的组合物,以及它们用于治疗、预防和/或管理疾病或紊乱的方法:。
    公开号:
    CN104045626B
点击查看最新优质反应信息

文献信息

  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION EN TANT QUE PESTICIDES
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162072A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, or a C3-C12 cycloalkyl group, etc., which each optionally be substituted; R2, R3, R4 and R5 represent independently of each other a hydrogen atom, a halogen atom or an C1-C3 alkyl group, etc.; R6 represents an C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom, a C1-C6 haloalkyl group, an C2-C6 alkenyl group, an C1-C6 alkoxy group, or a C1-C6 haloalkoxy group, etc.; R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, or an C1-C4 alkyl group, etc.; X represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。公式(1)的四唑酮化合物:[其中R1代表C6-C16芳基、C1-C12烷基或C3-C12环烷基等,每个都可以选择性地被取代;R2、R3、R4和R5分别独立地代表氢原子、卤素原子或C1-C3烷基等;R6代表C1-C6烷基、C3-C6环烷基、卤素原子、C1-C6卤代烷基、C2-C6烯基、C1-C6烷氧基或C1-C6卤代烷氧基等;R7、R8和R9分别独立地代表氢原子、卤素原子或C1-C4烷基等;X代表氧原子或硫原子;R10代表C1-C6烷基等]在杀虫方面表现出优异的控制效果。
  • Deoxytrifluoromethylthiolation and Selenylation of Alcohols by Using Benzothiazolium Reagents
    作者:Stefan Dix、Michael Jakob、Matthew N. Hopkinson
    DOI:10.1002/chem.201901607
    日期:2019.6.7
    Aliphatic compounds substituted with medicinally important trifluoromethylthio (SCF3) and trifluoromethylselenyl (SeCF3) groups were synthesized directly from alcohols by using the new benzothiazolium salts BT‐SCF3 and BT‐SeCF3. These bench‐stable fluorine‐containing reagents are facile to use and can be prepared in two steps from non‐fluorinated heteroaromatic starting materials. The metal‐free d
    使用新的苯并噻唑鎓盐BT-SCF 3和BT-SeCF 3从醇中直接合成被医学上重要的三氟甲硫基(SCF 3)和三氟甲基硒基(SeCF 3)取代的脂肪族化合物。这些台式稳定的含氟试剂易于使用,可以由非氟化杂芳族原料分两步制备。使用BT-SCF 3的无金属脱氧三氟甲基硫醇化过程在温和条件下进行,使用BT-SeCF 3的三氟甲基硒基化反应同样有效 据我们所知,这是首次报道这种转变的例子。
  • Fe(III)-catalyzed trityl benzyl ether formation and disproportionation cascade reactions to yield benzaldehydes
    作者:Xiaoyu Wang、Chuan Du、Hui Shi、Yadong Pang、Shengfei Jin、Yuqian Hou、Yanshi Wang、Xiaoshi Peng、Jianyong Xiao、Yang Liu、Yongxiang Liu、Maosheng Cheng
    DOI:10.1016/j.tet.2015.07.040
    日期:2015.9
    During investigating water-compatible Lewis acids catalyzed etherifications using alcohols as alkylating reagents directly, we developed Fe(III)-catalyzed trityl benzyl ether formations irradiated by microwave. Then an in situ trityl benzyl ether formation and disproportionation cascade reaction was achieved to yield the benzaldehyde products with good functional group tolerances under neat conditions
    在直接使用醇作为烷基化试剂研究与水相容的路易斯酸催化的醚化过程中,我们开发了Fe(III)催化的微波辐照的三苯甲基苄基醚形成。然后,在相对较高的温度下,在纯净条件下,实现了原位三苯甲基苄基醚的形成和歧化级联反应,从而得到具有良好官能团耐受性的苯甲醛产物。通过使用化学动力学图方法改变苄醇和三芳基甲醇上的取代基,探讨了底物对醚化和歧化的取代作用,并通过交叉实验研究了转化机理。醚化和歧化级联过程可以在实验室中方便地扩大规模,而不会损失很多效率。
  • HIV INTEGRASE INHIBITORS
    申请人:ViiV Healthcare Company
    公开号:US20150225399A1
    公开(公告)日:2015-08-13
    The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
    本发明具有作为HIV整合酶抑制剂的化合物,因此在抑制HIV复制、预防及/或治疗HIV感染以及治疗艾滋病及/或艾滋病相关综合症方面具有用途。
  • Synthesis of trifluoromethylated isoxazoles and their elaboration through inter- and intra-molecular C–H arylation
    作者:Jian-Siang Poh、Cristina García-Ruiz、Andrea Zúñiga、Francesca Meroni、David C. Blakemore、Duncan L. Browne、Steven V. Ley
    DOI:10.1039/c6ob00970k
    日期:——
    conditions for the preparation of a range of trifluoromethylated isoxazole building blocks through the cycloaddition reaction of trifluoromethyl nitrile oxide. It was found that controlling the rate (and therefore concentration) of the formation of the trifluoromethyl nitrile oxide was Critical for the preferential formation of the desired isoxazole products versus the furoxan dimer. Different conditions were
    我们报告了通过三氟甲基腈的环加成反应制备一系列三氟甲基化的异恶唑结构单元的条件。已发现控制三氟甲基丁腈氧化物的形成速率(以及浓度)对于优先形成所需的异恶唑产物比呋喃二聚体。针对芳基和烷基取代的炔烃优化了不同的条件。此外,已针对这些结构单元简要探讨了异恶唑4位的反应性。分子间CH-H芳基化,锂化和亲电淬灭以及烷氧基化的条件均通过简短的底物作用域确定,这表明对一系列功能的有用耐受性。最后,开发了通过分子内环化或分子间交叉偶联进行结构多样化的互补过程。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐